JOSHUA SIMMONS: Open Payments
NPI 1033987573 · WOODBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 19 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $682 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Gilead Sciences, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Insulet Corporation | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: REXULTI, MOUNJARO, Omnipod, VAXNEUVANCE, VRAYLAR, UBRELVY, HETLIOZ, GVOKE HYPOPEN.
Industry payments across NY — which companies pay providers there.
